3-(allyloxy)propan-1-amine | 105939-61-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-(allyloxy)propan-1-amine
• 英文别名: γ-Aminopropylallylaether；3-(Prop-2-en-1-yloxy)propan-1-amine；3-prop-2-enoxypropan-1-amine
• CAS: 105939-61-5
• 化学式: C₆H₁₃NO
• 分子量: 115.175
• InChiKey: NIGGRFSYIUCXTE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  8
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(allyloxy)propan-1-amine 在 三乙胺 、 sodium iodide 作用下， 以 乙醚 、 丙酮 为溶剂， 反应 13.0h， 生成 N-(3-allyloxypropyl)iodoacetamide
  参考文献：
  名称：

  四环 [ABCE] 中间体的趋同方法在 Aspidosperma 生物碱合成

  摘要：

  摘要 从反式六氢咔唑-4-one 1 和取代碘乙酰胺6 开始，实现了四环酰胺醇5 的高效收敛合成，这是合成Aspidosperma 生物碱骨架的关键中间体。

  DOI：

  10.1080/00397919208021293
• 作为产物：
  描述：

  3-(3-Azido-propoxy)-propene 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 反应 10.0h， 生成 3-(allyloxy)propan-1-amine
  参考文献：
  名称：

  四环 [ABCE] 中间体的趋同方法在 Aspidosperma 生物碱合成

  摘要：

  摘要 从反式六氢咔唑-4-one 1 和取代碘乙酰胺6 开始，实现了四环酰胺醇5 的高效收敛合成，这是合成Aspidosperma 生物碱骨架的关键中间体。

  DOI：

  10.1080/00397919208021293

文献信息

• A MEDICAMENT FOR TREATING INFLUENZA CHARACTERIZED BY COMBINING A CAP-DEPENDENT ENDONUCLEASE INHIBITOR AND AN ANTI-INFLUENZA DRUG
  申请人：Shionogi & Co., Ltd.

  公开号：US20200261481A1

  公开（公告）日：2020-08-20

  A medicament characterized in that (A) a compound represented by the formula (I): its pharmaceutically acceptable salt, or a solvate thereof, wherein P is hydrogen or a group to form a prodrug; A 1 is CR 1A R 1B , S or O; A 2 is CR 2A R 2B , S or O; A 3 is CR 3A R 3B , S or O; A 4 is each independently CR 4A R 4B , S or O; the number of hetero atoms among atoms constituting the ring which consists of A 1 , A 2 , A 3 , A 4 , nitrogen atom adjacent to A 1 and carbon atom adjacent to A 4 is 1 or 2; R 1A and R 1B are each independently hydrogen, halogen, alkyl or the like; R 2A and R 2B are each independently hydrogen, halogen, alkyl, or the like; R 3A and R 3B are each independently hydrogen, halogen, alkyl, or the like; R 4A are each independently hydrogen, halogen, alkyl, or the like; R 4B are each independently hydrogen, halogen, alkyl, or the like; R 3A and R 3B may be taken together with an adjacent carbon atom to form non-aromatic carbocycle or non-aromatic heterocycle; n is any integer of 1 to 2; and R 1 is or the like, is combined with (B) compound(s) having an anti-influenza activity, its pharmaceutically acceptable salt or a solvate thereof and/or an antibody having anti-influenza activity, is useful for treating or preventing influenza.

  一种药物，其特征在于（A）由以下式（I）表示的化合物： 其药学上可接受的盐，或其溶剂合物， 其中 P为氢或形成前药的基团; A 1 为CR 1A R 1B 、S或O; A 2 为CR 2A R 2B 、S或O; A 3 为CR 3A R 3B 、S或O; A 4 分别为独立的CR 4A R 4B 、S或O; 构成由A 1 、A 2 、A 3 、A 4 、邻接到A 1 的氮原子和邻接到A 4 的碳原子的环的原子中的杂原子数为1或2; R 1A 和R 1B 分别为独立的氢、卤素、烷基或类似物; R 2A 和R 2B 分别为独立的氢、卤素、烷基或类似物; R 3A 和R 3B 分别为独立的氢、卤素、烷基或类似物; R 4A 分别为独立的氢、卤素、烷基或类似物; R 4B 分别为独立的氢、卤素、烷基或类似物; R 3A 和R 3B 可以与相邻的碳原子结合形成非芳香碳环或非芳香杂环; n为1到2的任意整数; 和 R 1 为 或类似物， 与具有抗流感活性的（B）化合物，其药学上可接受的盐或其溶剂合物和/或具有抗流感活性的抗体结合，用于治疗或预防流感。
• [EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSÉS CHIMIQUES
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2019053617A1

  公开（公告）日：2019-03-21

  The invention is directed to substituted salicylamide derivatives. Specifically, the invention is directed to compounds according to FormµLa (I): wherein R, R1,P, X, Y, and Z are as defined herein; or a pharmaceutically acceptable salt thereof. The compounds of the invention are inhibitors of CD73 and can be usefµL in the treatment of cancer, pre-cancerous syndromes and diseases associated with CD73 inhibition, such as AIDS, the treatment of HIV, autoimmune diseases, infections, atherosclerosis, and ischemia–reperfusion injury. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CD73 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

  本发明涉及取代水杨酰胺衍生物。具体而言，本发明涉及式I化合物：其中R，R1，P，X，Y和Z定义如本文中；或其药用可接受盐。本发明的化合物是CD73的抑制剂，可用于治疗癌症、前癌症综合症以及与CD73抑制相关的疾病，例如艾滋病、治疗HIV、自身免疫疾病、感染、动脉粥样硬化和缺血再灌注损伤。因此，本发明进一步涉及包含本发明化合物的药物组合物。本发明进一步涉及使用本发明化合物或包含本发明化合物的药物组合物抑制CD73活性和治疗相关疾病的方法。
• [EN] BISUREA GELLING AGENTS AND COMPOSITIONS<br/>[FR] AGENTS GÉLIFIANTS DE TYPE BIURÉE ET COMPOSITIONS ASSOCIÉES
  申请人：MILLIKEN & CO

  公开号：WO2013033300A1

  公开（公告）日：2013-03-07

  Bisurea gelling agents that impart a number of unexpected benefits within various gelled formulations and exhibit great versatility in terms of gelling capabilities for many types of solvents are provided. Such gelling agents should include pendant groups, such as sterically hindering alkyl groups attached to polyoxyalkylenated moieties that allow the gelling agent to be compatible with the target liquid system at elevated temperatures, while controlling and/or limiting the network formation and strength during the cooling cycle. The result is that a reliable, hard gel is formed that does not crash out of solution easily and that does not exhibit unwanted cracking or precipitating out within the final formulation. Alternatively, novel gelling agents having two urea groups but that are asymmetrical in configuration have been produced in order to provide the same control in temperature, compatibility, and efficiency. Final gelled formulations, such as antiperspirant sticks and other like consumer items, are provided as well within this invention.

  本文提供了一种Bisurea凝胶剂，它在各种凝胶配方中带来了许多意想不到的好处，并且在凝胶能力方面表现出极大的多样性，适用于许多类型的溶剂。这种凝胶剂应包括挂链基团，例如附加到聚氧烷基化物上的空间阻碍烷基基团，使凝胶剂在升高的温度下与目标液体系统兼容，同时在冷却周期中控制和/或限制网络形成和强度。结果是形成了可靠的坚硬凝胶，不易从溶液中崩解，不会在最终配方中出现不必要的开裂或沉淀。另外，为了提供相同的温度、兼容性和效率控制，还制备了具有两个脲基但配置不对称的新型凝胶剂。本发明还提供了最终的凝胶配方，例如止汗膏和其他类似的消费品。
• IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS
  申请人：GIVAUDAN SA

  公开号：US20170297992A1

  公开（公告）日：2017-10-19

  A fragrance precursor of 3-(4-isobutyl-2-methyl phenyl)propanal, comprising at least an enamine and/or an aminal as reaction product of 3-(4-isobutyl-2-methylphenyl)propanal (compound according to formula (I)) and a primary and/or secondary amine useful as a perfume ingredient.

  一种3-(4-异丁基-2-甲基苯基)丙醛的香气前体，包括至少一种烯胺和/或氨缩醛，作为3-(4-异丁基-2-甲基苯基)丙醛（化合物式（I）所示的化合物）和初级和/或二级胺的反应产物，可作为香料成分。
• [EN] ENAMINE AND/OR AMINAL FRAGANCE PRECURSORS DERIVED FROM (E/Z)-9-HYDROXY-5,9-DIMETHYLDEC-4-ENAL<br/>[FR] PRÉCURSEURS DE PARFUM D'ÉNAMINE ET/OU D'AMINAL DÉRIVÉS D'(E/Z)-9-HYDROXY-5,9-DIMÉTHYLDEC-4-ÉNAL
  申请人：GIVAUDAN SA

  公开号：WO2016091899A1

  公开（公告）日：2016-06-16

  A fragrance precursor of (E/Z)-9-hydroxy-5,9-dimethyldec-4-enal, comprising at least an enamine and/or an aminal as reaction product of (E/Z)-9-hydroxy-5,9- dimethyldec-4-enal (compound according to formula (I)) and a primary and/or secondary amine useful as a perfume ingredient.

  (E/Z)-9-羟基-5,9-二甲基癸-4-烯醛的香气前体，包括至少一个恩酰和/或胺缩合物，作为(E/Z)-9-羟基-5,9-二甲基癸-4-烯醛（化合物式（I））和一种一级和/或二级胺的反应产物，可用作香料成分。